Table 3.
Predictor variables | Sub HR (95 % CI) | P Value |
---|---|---|
ALD (vs non-ALD) | 0.84 (0.81–0.87) | < 0.001 |
| ||
Age (vs 18–34) | ||
35–49 | 1.40 (1.26–1.56) | < 0.001 |
50–64 | 1.96 (1.77–2.16) | < 0.001 |
65 and older | 2.68 (2.42–2.98) | < 0.001 |
| ||
Female Sex | 1.10 (1.06–1.14) | < 0.001 |
| ||
Race (vs White) | ||
Black | 1.06 (1.00–1.13) | 0.048 |
Other | 1.05 (1.00–1.09) | 0.03 |
| ||
BMI (vs 20–29) | ||
Less than 20 | 1.53 (1.40–1.67) | < 0.001 |
30–34 | 0.94 (0.91–0.98) | 0.003 |
35–39 | 0.94 (0.89–0.99) | 0.01 |
> or = 40 | 1.12 (1.05–1.20) | < 0.001 |
| ||
Blood group (vs AB) | ||
A | 1.72 (1.55–1.92) | < 0.001 |
B | 1.44 (1.28–1.61) | < 0.001 |
O | 1.70 (1.53–1.89) | < 0.001 |
| ||
Ascites (vs Absent) | ||
Slight | 1.15 (1.09–1.22) | < 0.001 |
Moderate or more | 1.35 (1.28–1.44) | < 0.001 |
| ||
Spontaneous bacterial peritonitis | 1.08 (1.02–1.15) | 0.01 |
| ||
Encephalopathy (vs none) | ||
Grade 1–2 | 1.29 (1.23–1.35) | < 0.001 |
Grade 3–4 | 3.63 (3.45–3.83) | < 0.001 |
| ||
Diabetes | 1.10 (1.07–1.15) | < 0.001 |
| ||
Prior malignancy | 1.15 (1.08–1.23) | < 0.001 |
| ||
MELD at listing (vs < 15) | ||
15–24 | 1.42 (1.37–1.47) | < 0.001 |
25–34 | 1.53 (1.46–1.62) | < 0.001 |
≥ 35 | 1.88 (1.76–2.00) | < 0.001 |
| ||
Region for listing, by grouping of wait-time (vs short) | ||
Moderate | 1.34 (1.29–1.39) | < 0.001 |
Long | 1.52 (1.45–1.58) | < 0.001 |
| ||
Cohort (vs 2002–2006) | ||
2007–2011 | 1.06 (1.02–1.10) | 0.004 |
2012–2016 | 1.03 (0.99–1.08) | 0.14 |